Structure Therapeutics Appoints Ted W. Love, M.D., to Board of Directors

<p>SAN FRANCISCO, Aug. 03, 2023 (GLOBE NEWSWIRE) — Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and pulmonary diseases, today announced that it has appointed Ted W. Love, M.D., to its Board of Directors. Dr. Love brings more than 30 years of experience in the […]</p>
<p>The post <a rel="nofollow" href="https://forextv.com/top-news/structure-therapeutics-appoints-ted-w-love-m-d-to-board-of-directors/">Structure Therapeutics Appoints Ted W. Love, M.D., to Board of Directors</a> appeared first on <a rel="nofollow" href="https://forextv.com">ForexTV</a>.</p>